Therapy-related myelodysplasia and/or acute myeloid leukaemia after autologous haematopoietic progenitor cell transplantation in a prospective single centre cohort of 221 patients

British Journal of Haematology

Volumn 122, Issue 1, 2003, Pages 109-117

  Beauchamp Nicoud, Anne ^a   Feneux, Danielle ^a   Bayle, Chantal ^b   Bernheim, Alain ^b   Léonard, Claude ^a   Koscielny, Serge ^b   Tchernia, Gil ^a   Bourhis, Jean Henri ^b  

^a BICÊTRE HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Autologous haematopoietic progenitor cell transplantation; Telomere length; Therapy related leukaemia; Therapy related myelodysplasia

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; CLONOGENESIS; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FOLLICULAR LYMPHOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MYELODYSPLASTIC SYNDROME; MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; TELOMERE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BONE MARROW EXAMINATION; CHROMOSOME ABERRATIONS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; PROSPECTIVE STUDIES; TELOMERE;

EID: 0038345305     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04388.x     Document Type: Article

References (51)

1. Abruzzese, E., Radford, J.E., Miller, J.S., Vredenburgh, J.J., Nagesh Rao, P., Pettenati, M.J., Cruz, J.M., Perry, J.J., Amadori, S. & Hurd, D.D. (1999) Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantation. Blood, 94, 1814-1819.
2. Akiyama, M., Asai, O., Kuraishi, Y., Urashima, M., Hoshi, Y., Sakamaki, H., Yabe, H., Furukawa, T., Yamada, O., Mizoguchi, H. & Yamada, H. (2000) Shortening of telomeres in recipients of both autologous and allogenic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 25, 441-447.
3. Allsopp, R.C., Cheshier, S. & Weissmann, I.L. (2001) Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. Journal of Experimental Medicine, 193, 917-924.
4. Amigo, M.L., del Cañizo, M.C., Rios, A., Garcia, M.A., Caballero, M.D., Martin, A., Bermejo, N., Vilches, P. & San Miguel, J.F. (1999) Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS. Bone Marrow Transplantation, 23, 997-1002.
5. Andre, M., Henry-Amar, M., Blaise, D., Colombat, P., Fleury, J., Milpied, N., Cahn, J.Y., Pico, J.L., Bastion, Y., Kuentz, M., Nedellec, G., Attal, M., Fermé, C. & Gisselbrecht, C. for the Société Française de Greffe de Moelle (1998) Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease. Blood, 92, 1933-1940.
6. Bathia, S., Ramsay, N., Steinbuch, M., Dusenbery, K.E., Shapiro, R.S., Weisdorf, D.J., Robinson, L.L. & Neglia, J.P. (1996) Malignant neoplasms following bone marrow transplantation. Blood, 87, 3633-3639.
7. Baynes, R.D., Dansey, R.D., Klein, J.L., Hamm, C., Campell, M., Abella, E. & Peters, W.P. (2001) High-dose chemotherapy and hematopoietic stem cell transplantation for breast cancer: past or future? Seminars in Oncology, 28, 377-388.
8. Bjorkstrand, B. (2001) European group for blood and bone marrow transplantation registry studies in multiple myeloma. Seminars in Hematology, 38, 219-225.
9. Boultwood, J., Filder, C., Kusec, R., Rack, K., Elliot, P.J.W., Atoyebi, O., Chapman, R., Oscier, D.G. & Wainscoat, J.S. (1997) Telomere length in myelodysplastic syndromes. American Journal of Hematology, 56, 266-271.
10. Ching-Hon, P. (2000) Topoisomerase II inhibitor-related acute myeloid leukemia. British Journal of Haematology, 109, 13-23.
11. Darrington, D.L., Vose, J.M., Anderson, J.R., Bierman, P.J., Bishop, M.R., Chan, W.C., Morris, M.E., Reed, E.C., Sanger, W.G., Tarantolo, S.R., Weisenburger, D.D., Kessinger, A. & Armitage, J.O. (1994) Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. Journal of Clinical Oncology, 12, 2527-2534.
12. Gianni, A.M., Bregni, M., Siena, S., Brambilla, C., Di Nicola, M., Lombardi, F., Gandola, L., Tarella, C., Pireli, A., Ravagnani, F., Valagussa, P., Bonadonna, G., Stern, A.C., Magni, M. & Caracciolo, D. (1997) High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. New England Journal of Medicine, 336, 1290-1297.
13. Greenberg, P., Cox, C., Le Beau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennett, J. (1997) International scoring system for evaluation prognosis in myelodysplastic syndromes. Blood, 89, 2079-2088.
14. Haioun, C., Lepage, E., Gisselbrecht, C., Bastion, Y., Coiffier, B., Brice, P., Bosly, A., Dupriez, B., Nouvel, C., Tilly, H., Lederlin, P., Biron, P., Brière, J., Gaulard, P. & Reyes, F. for the Groupe d'Etude des Lymphomes de l'Adulte (1997) Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Journal of Clinical Oncology, 15, 1131-1137.
15. Hande, P.M., Samper, E., Lansdorp, P. & Blasco, M.A. (1999) Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. Journal of Cell Biology, 144, 589-601.
16. Harousseau, J.L. (1999) Optimizing peripheral blood progenitor cell autologous transplantation in multiple myeloma. Haematologica, 84, 548-553.
17. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, K., Vardiman, J., Lister, T.A. & Bloomfield, C.D. (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. Journal of Clinical Oncology, 17, 3835-3849.
18. ISCN (1995) An International System for Human Cytogenetic Nomenclature (ed. by F. Mitelman), Published in collaboration with Cytogenetics and Cell Genetics. Karger, Basel.
19. Kohda, K., Sakamaki, S., Matsunaga, T., Kuga, T., Fujimi, A., Konuma, Y., Kusabe, T., Kogawa, K., Akiyama, T., Koike, K., Hirayama, Y., Sasagawa, Y., Nojiri, T., Hirata, Y., Nishisato, T., Niitsu, G.Y. & Hokkaido Society of Peripheral Blood Stem Cell Transplantation (2001) Long-term survival and late-onset complications of cancer patients treated with high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation. International Journal of Haematology, 73, 251-257.
20. Kohn, H.I. & Fry, R.J. (1984) Radiation carcinogenesis. New England Journal of Medicine, 310, 504-511.
21. Lansdorp, P.M. (1995) Telomere length and proliferation potential of hematopoietic stem cells. Journal of Cell Science, 108, 1-6.
22. Laurenti, L., d'Onofrio, G., Sica, S., Chiusolo, P., Zini, G., Piccirillo, N., Zollino, M., Garzia, M., Sorà, F. & Leone, G. (2000) Secondary myelodysplastic syndromes following peripheral blood stem cell transplantation: morphological, cytogenetic and clonality evaluation and the limitation of FAB criteria. Bone Marrow Transplantation, 26, 241-242.
23. Lee, J.J., Kook, H., Chung, H.J., Kim, H.J., Park, M.R., Kim, C.J., Nah, J.A. & Hwang, T.J. (1999) Telomere length changes in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplantation, 24, 411-415.
24. Levine, E.G. & Bloomfield, C.D. (1992) Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Seminars in Oncology, 19, 47-84.
25. Lodoño-Vallejo, J.A., DerSarkissian, H., Cazes, L. & Thomas, G. (2001) Differences in telomere length between homologous chromosomes in humans. Nucleic Acids Research, 29, 3164-3171.
26. Micallef, I., Lillington, D., Apostolidis, J., Amess, J., Neat, M., Matthews, J., Clark, T., Foran, J., Salam, A., Lister, A. & Rohatiner, A. (2000) Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. Journal of Clinical Oncology, 18, 947-955.
27. Miller, J.S., Arthur, D.C., Craig, E., Neglia, J.P., Miller, W.J. & Weisdorf, D.J. (1994) Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood, 83, 3780-3786.
28. Milligan, D.W., Ruiz de Elvira, M.C., Kolb, H.-J., Goldstone, A.H., Meloni, G., Rohatiner, A.Z., Colombat, P. & Schmitz, N. (1999) Secondary leukaemia and myelodysplasia after autografting for lymphoma: results of the EBMT. British Journal of Haematology, 106, 1020-1026.
29. Mink, S.A. & Armitage, J.O. (2001) High-dose therapy in lymphomas: a review of the current status of allogenic and autologous stem cell transplantation in Hodgkin's disease and non-Hodgkin's lymphomas. Oncologist, 6, 247-256.
30. Mounier, N. & Gisselbrecht, C. (2000) Myelodysplasia after autotransplantation. Journal of Clinical Oncology, 18, 3446-3447.
31. Neglia, J., Shapiro, R., Haake, R., Ramsay, N., McClave, P. & Kersey, J. (1992) Second neoplasms (SNs) following bone marrow transplantation (BMT). Blood, 80, 169a.
32. Ohyashiki, J.H., Ohyashiki, K., Fujimura, T., Kawakubo, K., Shimamoto, T., Iwabuchi, A. & Toyama, K. (1994) Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Research, 54, 3557-3560.
33. Ohyashiki, J.H., Iwama, H., Yahata, N., Ando, K., Hayashaki, S., Shay, J.W. & Ohyashiki, K. (1999) Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes. Clinical Cancer Research, 5, 1155-1160.
34. Ohyashiki, J.H., Sashida, G., Tauchi, T. & Ohyashiki, K. (2002) Telomeres and telomerase in hematologic neoplasia. Oncogene, 21, 680-687.
35. Pedersen-Bjergaard, J. & Philip, P. (1991a) Two different classes of therapy-related and de-novo acute myeloid leukemia. Cancer Genetics and Cytogenetics, 55, 119-124.
36. Pedersen-Bjergaard, J. & Philip, P. (1991b) Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase.
37. Pedersen-Bjergaard, J., Perdersen, M., Myhre, J. & Geisler, C. (1997) High risk therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure. Leukemia, 11, 1654-1660.
38. Pedersen-Bjergaard, J., Andersen, M.K. & Christiansen, D.H. (2000) Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation. Blood, 95, 3273-3279.
39. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harrousseau, J.L., Coiffier, B., Biron, P., Mandelli, F. & Chauvin, F. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non Hodgkin's lymphoma. New England Journal of Medicine, 333, 1540-1545.
40. Poon, S.S., Martens, U.M., Ward, R.K. & Lansdorp, P.M. (1999) Telomere length measurements using digital fluorescence microscopy. Cytometry, 36, 267-278.
41. Rosenfeld, C. & List, A. (2000) A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies. Leukemia, 14, 2-8.
42. Rozman, C., Feliu, E., Grañena, A., Brugues, R., Woessner, S. & Vives Corrons, J.L. (1982) Transient dyserythropoiesis in repopulated human bone marrow following transplantation: an ultrastructural study. British Journal of Haematology, 50, 63-73.
43. Smith, M.A., Rubinstein, L., Anderson, J.R., Arthur, D., Catalano, P.J., Freidlin, B., Heyn, R., Khayat, A., Krailo, M., Land, V.J., Miser, J., Shuster, J. & Vena, D. (1999) Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. Journal of Clinical Oncology, 17, 569-577.
44. Socié, G., Henry-Amar, M., Bacigalupo, A., Hows, J., Tichelli, A., Ljungman, P. & Gluckman, E. (1992) Malignancies occurring after the treatment for aplastic anemia: a survey on 1680 patients conducted by the European Group for Bone Marrow Transplantation (EBMT) Severe Aplastic Anemia Working Party. Blood, 80, 169a.
45. Soligo, D.A., Lambertenghi-Deliliers, G., Servida, F., Quirici, N., Campiglio, S., Tagliaferri, E., Oriani, A., Romitti, L., Della Volpe, A. & Annaloro, C. (1998) Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients. Bone Marrow Transplantation, 21, 15-22.
46. Speicher, M.R., Ballard, S. & Ward, D.C. (1996) Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nature Genetics, 12, 368-375.
47. Taylor, P.R.A., Jackson, G.H., Lennard, A.L., Hamilton, P.J. & Proctor, S.J. (1997) Low incidence of myelodysplastic syndrome following transplantation using autologous non-cryopreserved bone marrow. Leukemia, 11, 1650-1653.
48. - hematopoietic progenitors. Blood, 97, 1876-1878.
49. Wheeler, C., Khurshid, A., Ibrahim, J., Elias, A., Mauch, P., Ault, K. & Antin, J. (2001) Incidence of post-transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV). Leukemia and Lymphoma, 40, 499-509.
50. Wilson, C.S., Traweek, S.T., Slovak, M.L., Niland, J.C., Forman, S.J. & Brynes, R.K. (1997) Myelodysplastic syndrome occurring after autologous bone marrow transplantation for lymphoma. Morphologic features. American Journal of Clinical Pathology, 108, 369-377.
51. Witherspoon, R.P., Fisher, L.D., Schoch, G., Martin, P., Sullivan, K.M., Sanders, J., Deeg, H.J., Doney, K., Thomas, D., Storb, R. & Thomas, E.D. (1989) Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. New England Journal of Medicine, 321, 784-789.